These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 27062833)

  • 41. Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.
    Zhao HY; Zhou HY; Wang YT; Chen W; Qi SY; Cao JL; Li GH
    Chin Med J (Engl); 2016 Mar; 129(6):723-30. PubMed ID: 26960377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of shenqi fuzheng injection for assistance of chemotherapy in treating senile patients with non-small cell lung cancer].
    Liu CL; Chen WP; Cui SZ; Deng G; Liu L; Qin L; Su X; Yan B; Kong J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Oct; 24(10):901-3. PubMed ID: 15553823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A meta analysis of aidi injection plus taxotere and cisplatin in the treatment of non-small cell lung cancer].
    Wang Q; He X; Tian J; Wang X; Ru P; Ruan Z; Yang K
    Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1027-34. PubMed ID: 21081042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Shengmai injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: a meta-analysis.
    Duan B; Xie J; Rui Q; Zhang W; Xi Z
    Support Care Cancer; 2018 Jul; 26(7):2103-2111. PubMed ID: 29594484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of non-small cell lung cancer with Yiqi Buxue prescriptions combined with adjuvant chemotherapy on the cancer therapy-related cardiovascular toxicity: A systematic review and meta-analysis.
    Huang H; Liu B; Chen M; Qin Y; Li J; Li S; Xu X
    J Ethnopharmacol; 2024 Apr; 323():117665. PubMed ID: 38159818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Shenmai injection combined with platinum-containing first-line chemotherapy on quality of life, immune function and prognosis of patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis.
    Chen Y; Zhang C; Pan C; Yang Y; Liu J; Lv J; Pan G
    Medicine (Baltimore); 2021 Nov; 100(44):e27524. PubMed ID: 34871214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines.
    Chen H; Yao X; Li T; Lam CW; Zhang H; Wang J; Zhang W; Leung EL; Wu Q
    Medicine (Baltimore); 2019 Dec; 98(52):e18552. PubMed ID: 31876753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
    Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Single-Arm Phase II Study to Evaluate Efficacy and Safety of First-Line Treatment With DCVAC/LuCa, Standard of Care Chemotherapy and Shenqi Fuzheng Injection in Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer Patients.
    Liu Q; Lou Y; Li L; Yang G; Cui H; Cheng Z; Li Y; Liu M; Deng C; Wan D; Yan Y; Jia L
    Integr Cancer Ther; 2022; 21():15347354221083968. PubMed ID: 35313775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review.
    Chen S; Flower A; Ritchie A; Liu J; Molassiotis A; Yu H; Lewith G
    Lung Cancer; 2010 May; 68(2):137-45. PubMed ID: 20015572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Aidi Injection as an adjunct therapy for non-small cell lung cancer: a systematic review].
    Ma WH; Duan KN; Feng M; She B; Chen Y; Zhang RM
    Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):315-24. PubMed ID: 19361360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis.
    Zhang H; Chen T; Shan L
    Pharm Biol; 2019 Dec; 57(1):612-624. PubMed ID: 31522596
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
    Sun L; Ma JT; Zhang SL; Zou HW; Han CB
    Med Oncol; 2015 Feb; 32(2):473. PubMed ID: 25603953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials.
    Li X; Wang H; Lin W; Xu Q
    Curr Med Res Opin; 2014 Nov; 30(11):2295-304. PubMed ID: 24701984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review of β-elemene injection as adjunctive treatment for lung cancer.
    Wang B; Peng XX; Sun R; Li J; Zhan XR; Wu LJ; Wang SL; Xie T
    Chin J Integr Med; 2012 Nov; 18(11):813-23. PubMed ID: 23086485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials.
    McCulloch M; See C; Shu XJ; Broffman M; Kramer A; Fan WY; Gao J; Lieb W; Shieh K; Colford JM
    J Clin Oncol; 2006 Jan; 24(3):419-30. PubMed ID: 16421421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical value of Tongguanteng (Radix seu Herba Marsdeniae Tenacissimae) extract combined with chemotherapy in the treatment of advanced non-small cell lung cancer: a Meta-analysis].
    Zhang H; Zhang J; Ding H; Chen R; Liang F
    J Tradit Chin Med; 2016 Jun; 36(3):261-70. PubMed ID: 27468539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of cinobufacini injection combined with vinorelbine and cisplatin regimen chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Li Q; Liang RL; Yu QR; Tian DQ; Zhao LN; Wang WW; Xiao H; Yong XJ; Peng XD
    Medicine (Baltimore); 2020 Jul; 99(31):e21539. PubMed ID: 32756206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A network meta-analysis: The best Yiqi Fuzheng Chinese herbal injections for use based on the NP regimen to treat NSCLC.
    Luo H; Zheng W; Yan Q; Wang B; Ye B; Deng S; He F; Yang X; Wang X
    Medicine (Baltimore); 2020 Jul; 99(31):e20500. PubMed ID: 32756075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis.
    Cao A; He H; Wang Q; Li L; An Y; Zhou X
    Medicine (Baltimore); 2019 Mar; 98(11):e14798. PubMed ID: 30882655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.